Patient-reported Outcomes Following Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Overview

Journal EJHaem

Specialty Hematology

Date 2022 Jul 18

PMID 35844688

Authors

Noa Biran

Wanting Zhai

Roxanne E Jensen

Jeanne Mandelblatt

Susan Kumka

Rashmi Unawane

Kristi D Graves

David H Vesole

David S Siegel

Arnold L Potosky

Affiliations

Soon will be listed here.

Abstract

We evaluated changes in patient-reported outcomes and cognitive function from pre- to 3-6 months post-treatment among 42 newly diagnosed patients with multiple myeloma undergoing transplant with complete data using PROMIS-29. There were statistically significant improvements in physical ( < .001) and mental health ( < .001) but not cognition from pre-treatment to 3-6 month follow-up. Similar results were seen within age or comorbidity strata. Patients with myeloma undergoing transplant experienced generally improved short-term health outcomes with no significant declines in cognition.

Citing Articles

Patient-reported outcomes following autologous stem cell transplant for patients with multiple myeloma.

Biran N, Zhai W, Jensen R, Mandelblatt J, Kumka S, Unawane R EJHaem. 2022; 2(3):488-492.

PMID: 35844688 PMC: 9176031. DOI: 10.1002/jha2.231.

Bury-Kaminska M, Szudy-Szczyrek A, Nowaczynska A, Jankowska-Lecka O, Hus M, Kot K Brain Sci. 2021; 11(9).

PMID: 34573187 PMC: 8466339. DOI: 10.3390/brainsci11091166.

References

Attal M, Harousseau J, Stoppa A, Sotto J, Fuzibet J, Rossi J . A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. N Engl J Med. 1996; 335(2):91-7. DOI: 10.1056/NEJM199607113350204. View

Etto L, Morelli V, Silva V, Hungria V, Ciconelli R, Almeida M . Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients. Clinics (Sao Paulo). 2011; 66(11):1855-9. PMC: 3203955. DOI: 10.1590/s1807-59322011001100002. View

Niscola P, Scaramucci L, Efficace F . Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma. Expert Rev Hematol. 2019; 12(9):703-705. DOI: 10.1080/17474086.2019.1645005. View

Costa L, Huang J, Hari P . Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma. Biol Blood Marrow Transplant. 2015; 21(4):701-6. PMC: 4361014. DOI: 10.1016/j.bbmt.2014.12.024. View

Mandelblatt J, Small B, Luta G, Hurria A, Jim H, McDonald B . Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. J Clin Oncol. 2018; :JCO1800140. PMC: 7237199. DOI: 10.1200/JCO.18.00140. View

Jensen R, Moinpour C, Potosky A, Lobo T, Hahn E, Hays R . Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort. Cancer. 2016; 123(2):327-335. PMC: 5222745. DOI: 10.1002/cncr.30354. View

de Souza J, Yap B, Hlubocky F, Wroblewski K, Ratain M, Cella D . The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer. 2014; 120(20):3245-53. DOI: 10.1002/cncr.28814. View

Biran N, Zhai W, Jensen R, Mandelblatt J, Kumka S, Unawane R . Patient-reported outcomes following autologous stem cell transplant for patients with multiple myeloma. EJHaem. 2022; 2(3):488-492. PMC: 9176031. DOI: 10.1002/jha2.231. View

Yost K, Eton D, Garcia S, Cella D . Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol. 2011; 64(5):507-16. PMC: 3076200. DOI: 10.1016/j.jclinepi.2010.11.018. View

10.

Mandelblatt J, Stern R, Luta G, McGuckin M, Clapp J, Hurria A . Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?. J Clin Oncol. 2014; 32(18):1909-18. PMC: 4050204. DOI: 10.1200/JCO.2013.54.2050. View

11.

Henry E, Barry L, Hobbins A, McClure N, ONeill C . Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols. Value Health. 2020; 23(7):936-944. DOI: 10.1016/j.jval.2020.03.003. View

12.

Martino M, Rossi M, Ferreri A, Loteta B, Morabito A, Moscato T . Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials. Expert Rev Hematol. 2019; 12(8):665-684. DOI: 10.1080/17474086.2019.1634541. View

13.

Campagnaro E, Saliba R, Giralt S, Roden L, Mendoza F, Aleman A . Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 2008; 112(7):1617-24. DOI: 10.1002/cncr.23299. View